Novabiosis Inc. and Promethera Therapeutics Joint Release
Promethera Therapeutics SA, a pioneer in cell therapies for treatment of severe liver diseases, has divested certain assets of their US subsidiary, Promethera Biosciences, LLC.
- About Us
Our Company & Team
With our OPO partners we can help improve access to non-transplantable organs and more
Press Release
The latest news and development of Novabiosis and research community
Events & Announcements
View our calendar for upcoming events and important announcements
Contact Us
For more information about our primary cell products & services contact our customer support team
- Primary Cells
Animal Cells
- Mouse Cells:
- CD1
- C57/BL6
- Rat Cells:
- Sprague-Dawley
- Goat Cells
- Non Human Primate (NHP)
- Dog Cells
- Resources
Inventory Overview
Download a complete Inventory list to review for easy to use reference when placing an order.
Industry News
Insights to the research industry and current news for research cells discovery and success.